| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 6 | |
| #2 | Australia | 5 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | United Kingdom | 3 | |
| #5 | United States | 3 |
| # | Industry | |
|---|---|---|
| #1 | Organic fine chemistry | |
| #2 | Pharmaceuticals | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Acyclic or carbocyclic compounds | |
| #3 | Heterocyclic compounds | |
| #4 | Peptides | |
| #5 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Willems Henriette | 16 |
| #2 | Porter Barry | 12 |
| #3 | Gane Paul | 11 |
| #4 | Keavey Kenneth | 7 |
| #5 | Saroglou Lydia | 7 |
| #6 | Wijkmans Jac | 7 |
| #7 | Beckett Raymond Paul | 6 |
| #8 | Harris William | 2 |
| #9 | John Derek Edward | 2 |
| #10 | Harris William H | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2004096808A1 | Triazine compounds and their use | |
| GB0300805D0 | Substituted 1,3,5-triazine derivatives | |
| AU2002365650A1 | Bacterial enzyme inhibitors | |
| GB0220215D0 | Protected amino acid derivatives for the treatment of alzheimer's disease | |
| AU1624902A | Antimicrobial agents |